N631 Exam 1 Study Guide With
Complete Solutions
Tanner Stage II - ANSWER A young female has bilateral breast buds. This
represents Tanner Stage:
I
II
III
IV
Tanner Stage I - ANSWER prepubertal
Tanner Stage II - ANSWER Female: Breast budding, areolar hyperplasia with
small amount of breast tissue
Male: red scrotal skin, enlargement of testes
Pubic hair: downy, sparse
Tanner Stage III - ANSWER Female: Further enlargement of breast tissue and
areola, increased amount of pubic hair, menarche for 2%.
Male: Further enlargement of scrotum, significant enlargement, especially in
diameter of penis. Increase in amount and curling of pubic hair
Tanner Stage IV - ANSWER Female: Separation of contours; areola and nipple
form secondary mound above breasts tissue. public hair adult in type but not in
distribution Menarche occurs in most girls in this stage, 1-3 years after
thelarche.
Male: Further enlargement of penis and scrotum.
Pubic hair adult in type but not in distribution. Development of axillary hair and
some facial hair
Tanner Stage V - ANSWER Adult characteristics
The U.S. Preventative Task Force (USPSTF) rating A - ANSWER The USPSTF
recommends the service. There is high certainty that the net benefit is
substantial and they recommend to offer or provide the service. Offer/provide
this service.
The U.S. Preventative Task Force (USPSTF) rating B - ANSWER The USPSTF
recommends the service. There is high certainty that the net benefit is moderate
or there is moderate certainty that the net benefit is moderate to substantial and
they recommend to offer or provide the service. Offer/provide this service
, The U.S. Preventative Task Force (USPSTF) rating C - ANSWER The USPSTF
recommends selectively offering or providing this service to individual patients
based on professional judgment and patient preferences. There is at least
moderate certainty that the net benefit is small. They recommend to offer or
provide this service based on the individuals circumstances. Offer/provide this
service only if other considerations support the offering or providing of this
service to this individual patient.
The U.S. Preventative Task Force (USPSTF) rating D - ANSWER The USPSTF
recommends against the service. There is moderate or high certainty that the
service has no net benefit or that the harms outweigh the benefits. They
discourage the use of this service.
True or False: Developing encephalitis within 15 days of a measles, mumps and
rubella (MMR) vaccine is a reportable adverse event. - ANSWER True: According
to the Centers for Disease Control and Prevention (CDC), if a patient develops
encephalitis within 15 days of the MMR vaccine, it should be reported to the
VAERS immediately (2017).
True or False: Anaphylaxis 21 days after a Tdap vaccine is a reportable event. -
ANSWER False; The CDC in its VAERS Table of Reportable Events notes that
anaphylaxis 7 days after the Tdap vaccine is a reportable event, not 21 days
(2017).
True or False: Chronic arthritis within 7 days of a Tdap vaccine is a reportable
event. - ANSWER False. In the CDC VAERS Table of Reportable Events, chronic
arthritis is a reportable event if it occurs within 42 days of administration of the
MMR vaccine, not 7 days within the Tdap vaccine (2017).
True or False: Thrombocytopenic purpura 7 days after a Tdap vaccine is a
reportable event. - ANSWER False. The CDC in its VAERS Table of Reportable
Events states that thrombocytopenic purpura 7 days after the MMR vaccine is a
reportable event, not the Tdap vaccine (2017).
The U.S. Preventative Task Force (USPSTF) rating I - ANSWER The USPSTF
concludes that the current evidence is insufficient to assess the balance of
benefits and harms of the service. Evidence is lacking, of poor quality, or
conflicting, and the balance of benefits and harms cannot be determined.
They were uninsured - ANSWER A 7-year-old patient presents to your primary
care clinic for immunizations. They would be eligible to receive VFC vaccine if:
They were uninsured
They were under the age 18
Were born in Mexico
Complete Solutions
Tanner Stage II - ANSWER A young female has bilateral breast buds. This
represents Tanner Stage:
I
II
III
IV
Tanner Stage I - ANSWER prepubertal
Tanner Stage II - ANSWER Female: Breast budding, areolar hyperplasia with
small amount of breast tissue
Male: red scrotal skin, enlargement of testes
Pubic hair: downy, sparse
Tanner Stage III - ANSWER Female: Further enlargement of breast tissue and
areola, increased amount of pubic hair, menarche for 2%.
Male: Further enlargement of scrotum, significant enlargement, especially in
diameter of penis. Increase in amount and curling of pubic hair
Tanner Stage IV - ANSWER Female: Separation of contours; areola and nipple
form secondary mound above breasts tissue. public hair adult in type but not in
distribution Menarche occurs in most girls in this stage, 1-3 years after
thelarche.
Male: Further enlargement of penis and scrotum.
Pubic hair adult in type but not in distribution. Development of axillary hair and
some facial hair
Tanner Stage V - ANSWER Adult characteristics
The U.S. Preventative Task Force (USPSTF) rating A - ANSWER The USPSTF
recommends the service. There is high certainty that the net benefit is
substantial and they recommend to offer or provide the service. Offer/provide
this service.
The U.S. Preventative Task Force (USPSTF) rating B - ANSWER The USPSTF
recommends the service. There is high certainty that the net benefit is moderate
or there is moderate certainty that the net benefit is moderate to substantial and
they recommend to offer or provide the service. Offer/provide this service
, The U.S. Preventative Task Force (USPSTF) rating C - ANSWER The USPSTF
recommends selectively offering or providing this service to individual patients
based on professional judgment and patient preferences. There is at least
moderate certainty that the net benefit is small. They recommend to offer or
provide this service based on the individuals circumstances. Offer/provide this
service only if other considerations support the offering or providing of this
service to this individual patient.
The U.S. Preventative Task Force (USPSTF) rating D - ANSWER The USPSTF
recommends against the service. There is moderate or high certainty that the
service has no net benefit or that the harms outweigh the benefits. They
discourage the use of this service.
True or False: Developing encephalitis within 15 days of a measles, mumps and
rubella (MMR) vaccine is a reportable adverse event. - ANSWER True: According
to the Centers for Disease Control and Prevention (CDC), if a patient develops
encephalitis within 15 days of the MMR vaccine, it should be reported to the
VAERS immediately (2017).
True or False: Anaphylaxis 21 days after a Tdap vaccine is a reportable event. -
ANSWER False; The CDC in its VAERS Table of Reportable Events notes that
anaphylaxis 7 days after the Tdap vaccine is a reportable event, not 21 days
(2017).
True or False: Chronic arthritis within 7 days of a Tdap vaccine is a reportable
event. - ANSWER False. In the CDC VAERS Table of Reportable Events, chronic
arthritis is a reportable event if it occurs within 42 days of administration of the
MMR vaccine, not 7 days within the Tdap vaccine (2017).
True or False: Thrombocytopenic purpura 7 days after a Tdap vaccine is a
reportable event. - ANSWER False. The CDC in its VAERS Table of Reportable
Events states that thrombocytopenic purpura 7 days after the MMR vaccine is a
reportable event, not the Tdap vaccine (2017).
The U.S. Preventative Task Force (USPSTF) rating I - ANSWER The USPSTF
concludes that the current evidence is insufficient to assess the balance of
benefits and harms of the service. Evidence is lacking, of poor quality, or
conflicting, and the balance of benefits and harms cannot be determined.
They were uninsured - ANSWER A 7-year-old patient presents to your primary
care clinic for immunizations. They would be eligible to receive VFC vaccine if:
They were uninsured
They were under the age 18
Were born in Mexico